{"id":6813,"date":"2025-12-01T15:36:35","date_gmt":"2025-12-01T15:36:35","guid":{"rendered":"https:\/\/www.med.unc.edu\/obgyn\/?p=6813"},"modified":"2025-12-01T15:38:13","modified_gmt":"2025-12-01T15:38:13","slug":"dr-chemtai-mungo-named-robert-a-winn-career-development-award-scholar","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/obgyn\/2025\/12\/01\/dr-chemtai-mungo-named-robert-a-winn-career-development-award-scholar\/","title":{"rendered":"Dr. Chemtai Mungo named Robert A. Winn Career Development Award Scholar"},"content":{"rendered":"
CHAPEL HILL, N.C<\/strong>\u2014 Chemtai Mungo, MD, MPH, FACOG, an assistant professor in the UNC School of Medicine\u2019s Department of Obstetrics and Gynecology and affiliate faculty at the UNC Lineberger Comprehensive Cancer Center,<\/a> the Center for AIDS Research<\/a> and the UNC Institute of Global Health and Infectious Diseases<\/a> has been selected for the Robert A. Winn Excellence in Clinical Trials: Career Development Award (Winn CDA)<\/strong>, a prestigious two-year national program that trains early-career physicians to design and lead community-centered clinical trials.<\/div>\n
\u00a0<\/div>\n
\"Dr.The Winn CDA is part of the Robert A. Winn Diversity in Clinical Trials Award Program , a multi-year, $100M+ public\u2013private initiative established by the Bristol Myers Squibb Foundation with partners including Gilead Sciences, Amgen, Genentech, and the American Association of Cancer Research (AACR). The program\u2019s mission is to increase diversity in clinical trials, transform the clinical research landscape, and ensure that treatments are tested, safe, and effective for all <\/em>patients\u2014especially those in communities that have historically been excluded from research.<\/div>\n
\u00a0<\/div>\n
\n
\n

Dr. Chemtai Mungo<\/a> is a physician-scientist whose work focuses on secondary prevention of cervical cancer in low-resource settings, with a particular emphasis on self-administered vaginal therapies for cervical precancer in low- and middle-income countries (LMICs), where shortages of trained surgical providers and structural barriers to care are common. She currently leads NIH-funded clinical research aimed at improving human papillomavirus (HPV) treatment outcomes among women living with HIV in Africa and at understanding how the vaginal microbiome shapes responses to novel therapies.<\/p>\n

\n

\u201cHaving grown up in Kenya and now caring for patients in North Carolina, I see every day how where <\/em>you live still determines whether you have access to timely, life-saving care,\u201d Mungo said. \u201cThe Winn CDA will help me design clinical trials that are rooted in partnership with communities\u2014whether in Africa or rural counties in the U.S.\u2014so that women at highest risk for cervical cancer can benefit from the very science their needs inspire.\u201d<\/p>\n<\/blockquote>\n

\n

Cervical cancer remains one of the starkest examples of global inequity: an estimated 85\u201390% of new cases and deaths occur in LMICs<\/strong>, yet cancer clinical trials enroll few patients in these settings and are often led by investigators in high-income countries, limiting relevance to the populations who bear the greatest burden. In the United States, similar patterns of inequity are evident\u2014recent national data<\/a> show that cervical cancer incidence is roughly 25% higher and mortality 42% higher in rural counties compared with urban areas<\/strong>, reflecting persistent gaps in screening, diagnosis, and treatment access.<\/p>\n<\/div>\n

\n

Dr. Chemtai Mungo\u2019s research agenda directly targets these gaps by testing feasible, self-administered treatments that can be delivered closer to home, building clinical trial partnerships with public hospitals and safety-net clinics, and mentoring trainees who are committed to advancing health equity in both LMICs and underserved U.S. communities.<\/p>\n

\"\"
Clinical Trial Training Workshop in New Mexico run by AACR<\/figcaption><\/figure>
\"\"
Clinical Trial Training Workshop in New Mexico run by AACR<\/figcaption><\/figure>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CHAPEL HILL, N.C\u2014 Chemtai Mungo, MD, MPH, FACOG, an assistant professor in the UNC School of Medicine\u2019s Department of Obstetrics and Gynecology and affiliate faculty at the UNC Lineberger Comprehensive Cancer Center, the Center for AIDS Research and the UNC Institute of Global Health and Infectious Diseases has been selected for the Robert A. Winn … Read more<\/a><\/p>\n","protected":false},"author":116513,"featured_media":6819,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"layout":"","cellInformation":"","apiCallInformation":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[152,49,165],"tags":[],"class_list":["post-6813","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-obstetrics-gynecology-midwifery","category-news","category-research","odd"],"acf":[],"featured_image":"https:\/\/www.med.unc.edu\/obgyn\/wp-content\/uploads\/sites\/1360\/2025\/12\/chemtai-Robert-Winn-group-scaled.jpg","featured_image_medium":"https:\/\/www.med.unc.edu\/obgyn\/wp-content\/uploads\/sites\/1360\/2025\/12\/chemtai-Robert-Winn-group-300x225.jpg","featured_image_medium_large":"https:\/\/www.med.unc.edu\/obgyn\/wp-content\/uploads\/sites\/1360\/2025\/12\/chemtai-Robert-Winn-group-768x576.jpg","featured_image_large":"https:\/\/www.med.unc.edu\/obgyn\/wp-content\/uploads\/sites\/1360\/2025\/12\/chemtai-Robert-Winn-group-1024x768.jpg","featured_image_thumbnail":"https:\/\/www.med.unc.edu\/obgyn\/wp-content\/uploads\/sites\/1360\/2025\/12\/chemtai-Robert-Winn-group-150x150.jpg","featured_image_alt":"","category_details":[{"name":"General Obstetrics, Gynecology, & Midwifery","link":"https:\/\/www.med.unc.edu\/obgyn\/category\/general-obstetrics-gynecology-midwifery\/"},{"name":"News","link":"https:\/\/www.med.unc.edu\/obgyn\/category\/news\/"},{"name":"Research","link":"https:\/\/www.med.unc.edu\/obgyn\/category\/research\/"}],"tag_details":[],"_links_to":[],"_links_to_target":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/obgyn\/wp-json\/wp\/v2\/posts\/6813","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/obgyn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.med.unc.edu\/obgyn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/obgyn\/wp-json\/wp\/v2\/users\/116513"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/obgyn\/wp-json\/wp\/v2\/comments?post=6813"}],"version-history":[{"count":6,"href":"https:\/\/www.med.unc.edu\/obgyn\/wp-json\/wp\/v2\/posts\/6813\/revisions"}],"predecessor-version":[{"id":6822,"href":"https:\/\/www.med.unc.edu\/obgyn\/wp-json\/wp\/v2\/posts\/6813\/revisions\/6822"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/obgyn\/wp-json\/wp\/v2\/media\/6819"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/obgyn\/wp-json\/wp\/v2\/media?parent=6813"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.med.unc.edu\/obgyn\/wp-json\/wp\/v2\/categories?post=6813"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.med.unc.edu\/obgyn\/wp-json\/wp\/v2\/tags?post=6813"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}